Research programme: drug discovery - Organon/Ozgene
Latest Information Update: 25 Jul 2008
At a glance
- Originator Organon; Ozgene
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Unspecified
Most Recent Events
- 24 Mar 2005 Preclinical trials in Undefined in Australia (unspecified route)
- 24 Mar 2005 Preclinical trials in Undefined in Netherlands (unspecified route)